statistiche ricercatore

Continente	#
NA - Nord America	860
EU - Europa	812
AS - Asia	562
SA - Sud America	72
AF - Africa	22
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	2.331

Nazione	#
US - Stati Uniti d'America	846
RU - Federazione Russa	359
SG - Singapore	209
CN - Cina	169
GB - Regno Unito	133
IT - Italia	101
VN - Vietnam	61
BR - Brasile	60
HK - Hong Kong	51
SE - Svezia	42
FR - Francia	36
DE - Germania	28
FI - Finlandia	28
IE - Irlanda	27
KR - Corea	16
UA - Ucraina	16
IN - India	12
CA - Canada	9
ID - Indonesia	9
ZA - Sudafrica	9
NL - Olanda	8
JP - Giappone	7
NG - Nigeria	7
PL - Polonia	7
ES - Italia	5
TR - Turchia	5
AT - Austria	4
BD - Bangladesh	4
MX - Messico	4
PK - Pakistan	4
AR - Argentina	3
BE - Belgio	3
CZ - Repubblica Ceca	3
AU - Australia	2
CL - Cile	2
CO - Colombia	2
IQ - Iraq	2
KE - Kenya	2
LB - Libano	2
LV - Lettonia	2
MY - Malesia	2
PY - Paraguay	2
A2 - ???statistics.table.value.countryCode.A2???	1
AE - Emirati Arabi Uniti	1
BH - Bahrain	1
BO - Bolivia	1
BW - Botswana	1
BY - Bielorussia	1
CH - Svizzera	1
EC - Ecuador	1
EE - Estonia	1
EG - Egitto	1
GR - Grecia	1
HR - Croazia	1
HU - Ungheria	1
JO - Giordania	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LU - Lussemburgo	1
MA - Marocco	1
MK - Macedonia	1
PH - Filippine	1
RS - Serbia	1
SA - Arabia Saudita	1
SI - Slovenia	1
TH - Thailandia	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	2.331

Nome	#
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3	251
Antigen specificity of immune suppression by myeloid-derived suppressor cells.	208
In vitro characterization of adipose stem cells non-enzymatically extracted from the thigh and abdomen	192
Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression	191
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes	190
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.	179
MDSCs in cancer: Conceiving new prognostic and therapeutic targets	168
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.	158
Myeloid-derived suppressor cell heterogeneity in human cancers	155
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.	140
Immunosuppressive activity of tumor-infiltrating myeloid cells in patients with meningioma	139
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy	132
Methods to Measure MDSC Immune Suppressive Activity In Vitro and In Vivo	128
Complexity and challenges in defining myeloid-derived suppressor cells	120
Totale	2.351

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	38	0	0	0	0	0	0	0	0	0	9	11	18
2021/2022	101	2	43	0	6	1	1	1	5	4	3	5	30
2022/2023	257	17	38	19	46	21	60	2	12	35	2	3	2
2023/2024	120	9	4	8	9	19	22	2	14	1	9	18	5
2024/2025	291	18	13	6	53	12	25	13	10	48	15	30	48
2025/2026	1.061	76	66	65	167	307	70	107	61	92	50	0	0
Totale													2.351

CATALOGO DEI PRODOTTI DELLA RICERCA